Table 2. Fasting blood lipid levels of the studies included in the male SCARB1 rs5888 subgroup.
Author/Year | CC | CT* | TT | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample size | TC, mmol/L | LDL-C, mmol/L | HDL-C, mmol/L | TG, mmol/L | Sample size | TC, mmol/L | LDL-C, mmol/L | HDL-C, mmol/L | TG, mmol/L | Sample size | TC, mmol/L | LDL-C, mmol/L | HDL-C, mmol/L | TG, mmol/L | |||||||||||||
MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | MEAN | SD | ||||
Acton.1999 | 54 | 5.48 | 1.14 | 3.72 | 1.14 | 1.16 | 0.36 | 1.11 | 0.66 | 104 | 5.28 | 1.21 | 3.59 | 1.21 | 1.19 | 0.49 | 1.08 | 0.60 | 34 | 5.40 | 1.14 | 3.67 | 1.09 | 1.24 | 0.39 | 1.06 | 0.67 |
Osgood.2003 | 327 | 5.22 | 1.08 | 3.41 | 0.90 | 1.09 | 0.36 | 1.39 | 0.18 | 556 | 5.21 | 1.18 | 3.38 | 1.18 | 1.12 | 0.24 | 1.33 | 0.24 | 294 | 5.10 | 1.03 | 3.26 | 0.86 | 1.15 | 0.34 | 1.31 | 0.17 |
Morabia.2004 | 280 | 5.76 | 1.00 | 3.92 | 0.84 | 1.17 | 0.33 | 1.26 | 0.50 | 436 | 5.77 | 1.04 | 3.90 | 0.84 | 1.22 | 0.21 | 1.22 | 0.42 | 149 | 5.80 | 0.98 | 3.90 | 0.85 | 1.24 | 0.24 | 1.24 | 0.49 |
Tanaka.2007 | 21 | 4.10 | 0.70 | 2.50 | 0.60 | 1.20 | 0.30 | 0.90 | 0.20 | 25 | 4.00 | 0.60 | 2.40 | 0.60 | 1.30 | 0.30 | 0.90 | 0.50 | 13 | 3.60 | 0.60 | 2.00 | 0.60 | 1.20 | 0.30 | 0.90 | 0.40 |
Wu1.2012 | 176 | 4.39 | 1.09 | 2.54 | 0.92 | 1.70 | 0.49 | 1.18 | 0.95 | 99 | 4.43 | 1.01 | 2.55 | 0.86 | 1.74 | 0.46 | 1.05 | 0.69 | 11 | 3.97 | 1.07 | 2.35 | 0.99 | 1.30 | 0.45 | 1.25 | 0.61 |
Wu2.2012 | 191 | 5.19 | 1.27 | 2.93 | 0.82 | 1.74 | 0.39 | 1.16 | 0.90 | 161 | 5.22 | 1.60 | 2.95 | 0.86 | 1.76 | 0.58 | 1.17 | 1.36 | 27 | 4.99 | 1.20 | 2.83 | 0.87 | 1.67 | 0.49 | 0.94 | 0.99 |
Wu3.2012 | 193 | 5.09 | 1.15 | 2.84 | 0.78 | 1.75 | 0.51 | 1.14 | 1.04 | 140 | 5.09 | 0.97 | 2.99 | 0.92 | 1.66 | 0.35 | 1.16 | 1.08 | 22 | 5.34 | 1.09 | 2.94 | 0.75 | 1.46 | 0.31 | 1.68 | 2.61 |
Smalinskiene.2013 | 149 | 5.30 | 1.10 | 3.29 | 0.98 | 1.26 | 0.49 | 1.68 | 0.40 | 212 | 5.29 | 1.02 | 3.40 | 1.02 | 1.32 | 0.44 | 1.53 | 0.49 | 63 | 5.56 | 1.03 | 3.66 | 0.95 | 1.27 | 0.40 | 1.60 | 0.44 |
Stanislovaitiene. 2013 | 307 | 5.49 | 1.05 | 3.48 | 1.05 | 1.35 | 0.35 | 1.50 | 0.70 | 440 | 5.49 | 1.05 | 3.53 | 1.05 | 1.38 | 0.42 | 1.43 | 0.84 | 155 | 5.70 | 1.12 | 3.68 | 1.00 | 1.36 | 0.37 | 1.57 | 0.75 |
Boekholdt.2006 | 157 | 0.88 | 0.19 | 248 | 0.94 | 0.23 | 141 | 0.93 | 0.22 | ||||||||||||||||||
GUO1.2015 | 31 | 4.94 | 0.98 | 2.84 | 0.87 | 1.18 | 0.27 | 2.46 | 2.60 | 20 | 4.94 | 0.72 | 3.12 | 0.55 | 1.22 | 0.19 | 1.50 | 0.54 | |||||||||
GUO2.2015 | 139 | 5.00 | 0.92 | 2.93 | 0.71 | 1.14 | 0.25 | 1.73 | 1.33 | 79 | 4.88 | 0.75 | 2.95 | 0.72 | 1.12 | 0.23 | 1.72 | 0.78 |
*In GUO1 and GUO2, data of “CT” and “TT” phenotype were merged. SD: standard deviation